Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer RNA Therapeutics, siRNA

Arthur Levin

PhD

🏢Avidity Biosciences🌐USA

Executive Vice President of Research

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Arthur Levin has decades of experience in oligonucleotide therapeutics from Isis Pharmaceuticals to Avidity Biosciences, where he leads development of antibody-oligonucleotide conjugates for targeted delivery. His work has contributed to the field of targeted siRNA and ASO for cancer and muscle disease. He is a senior figure in RNA therapeutics.

Share:

🧪Research Fields 研究领域

antibody oligonucleotide conjugates
siRNA targeting
muscle delivery
cancer targeted delivery
oligonucleotide chemistry

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Arthur Levin 的研究动态

Follow Arthur Levin's research updates

留下邮箱,当我们发布与 Arthur Levin(Avidity Biosciences)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment